Claims
- 1. A method of treating inflammatory diseases of the eye in a mammal which comprises administering to a mammal in need of such treatment a therapeutically effective amount of amorphous 3-[N-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin)-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoic acid, sodium salt.
- 2. The method of claim 1 wherein the mammal is man.
CROSS-REFERENCE
This is a division of application Ser. No. 07/973,491, filed Nov. 9, 1992, now U.S. Pat. No. 5,254,567, which is a continuation-in-part of U.S. Ser. No. 793,087, Nov. 15, 1991, abandoned.
Foreign Referenced Citations (1)
Number |
Date |
Country |
0419049 |
Mar 1991 |
EPX |
Non-Patent Literature Citations (3)
Entry |
Suryanarayanan & Mitchell, Inter. J. of Pharm., 24, 1-4 (1985). |
Byrn, S. R., Solid State Chem. of Drugs, pp. 10-11, Acad. Press. 1982. |
List of Amorphous Pharmaceuticals, Chem. Abst., 1967-1990. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
973491 |
Nov 1992 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
793087 |
Nov 1991 |
|